Non-Animal Models in Dermatological Research

被引:34
|
作者
Dellambra, Elena [1 ,4 ]
Odorisio, Teresa [1 ,4 ]
D'Arcangelo, Daniela [2 ,4 ]
Failla, Cristina M. [3 ,4 ]
Facchiano, Antonio [2 ,4 ]
机构
[1] IRCCS, IDI, Lab Mol & Cell Biol, Rome, Italy
[2] IRCCS, IDI, Lab Mol Oncol, Rome, Italy
[3] IRCCS, IDI, Lab Expt Immunol, Via Moriti di Creta 104, I-00167 Rome, Italy
[4] IRCCS, IDI, Working Grp ALMA, Rome, Italy
关键词
IN-VITRO MODEL; ADVANCED GLYCATION ENDPRODUCTS; HUMAN-MELANOMA PROGRESSION; HUMAN SKIN EQUIVALENT; DIABETIC FOOT ULCERS; WOUND-HEALING MODEL; HUMAN PROTEIN ATLAS; HUMAN CELL-LINES; TEST H-CLAT; RECONSTRUCTED-SKIN;
D O I
10.14573/altex.1808022
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Despite being widely used for basic and preclinical studies in dermatology, available animal models only partly recapitulate human skin features, often leading to disappointing outputs when preclinical results are translated to the clinic. Therefore, the need to develop alternative, non-animal models is widely recognized to more closely recapitulate human skin pathophysiology and to address the pressing ethical demand to reduce the number of animals used for research purposes, following the globally accepted 3Rs principle (Replacement, Reduction, and Refinement). Skin is the outermost organ of the body, and is, as such, easily accessible. Different skin cell types can be propagated in vitro, and skin can be reconstructed for therapeutic transplantation as well as for in vitro modelling of pathophysiological conditions. Bio-engineered skin substitutes have been developed and have evolved from elementary to complex systems, more and more closely resembling complete skin architecture and biological responses. In silico analyses take advantage of the huge amount of data already available from human studies to identify and model molecular pathways involved in skin pathophysiology without further animal testing. The present review recapitulates the available non-animal models for dermatological research and sheds light on their prospective technological evolution.
引用
收藏
页码:177 / 202
页数:26
相关论文
共 50 条
  • [41] Preclinical Development of Orally Inhaled Drugs (OIDs)-Are Animal Models Predictive or Shall We Move Towards In Vitro Non-Animal Models?
    Movia, Dania
    Prina-Mello, Adriele
    ANIMALS, 2020, 10 (08): : 1 - 16
  • [42] Harnessing opportunities in non-animal asthma research for a 21st-century science
    Buckland, Gemma L.
    DRUG DISCOVERY TODAY, 2011, 16 (21-22) : 914 - 927
  • [43] Progress and promise of alternative animal and non-animal methods in biomedical research (vol 97, pg 2329, 2023)
    Freires, Irlan Almeida
    Morelo, David Fernando Colon
    Ferreira Soares, Lelio Fernando
    Costa, Isabela Silva
    de Araujo, Leonardo Pereira
    Breseghello, Isadora
    Abdalla, Henrique Ballassini
    Lazarini, Josy Goldoni
    Rosalen, Pedro Luiz
    Pigossi, Suzane Cristina
    Franchin, Marcelo
    ARCHIVES OF TOXICOLOGY, 2023, 97 (11) : 3021 - 3021
  • [44] Animal and Non-Animal Experiments in Nanotechnology - the Results of a Critical Literature Survey
    Sauer, Ursula G.
    ALTEX-ALTERNATIVEN ZU TIEREXPERIMENTEN, 2009, 26 (02): : 109 - 134
  • [45] Alternative methods to animal experiments in the field of non-animal neurotoxicity testing
    Suñol, C
    Vendrell, I
    Rodríguez-Farré, E
    Martinez, M
    Burke, A
    Roi, A
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 197 (03) : 182 - 182
  • [46] Fur and Exotic Animal Materials: A Model for Luxury Non-Animal Embellishment
    Bailey-Cooper, Naomi
    LUXURY-HISTORY CULTURE CONSUMPTION, 2019, 6 (01): : 121 - 135
  • [47] Trends in the development of human stem cell-based non-animal drug testing models
    Lee, Su-Jin
    Lee, Hyang-Ae
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2020, 24 (06): : 441 - 452
  • [48] Alternative (Non-animal) method for TNFα production test
    Reyes, E
    Alonso-Lebrero, JL
    Brieva, A
    Mallo, AB
    Valdes-Hevia, MD
    Pivel, JP
    Alvarez-Mon, M
    PROCEEDINGS OF THE 6TH WORLD CONGRESS ON TRAUMA, SHOCK, INFLAMMATION AND SEPSIS- PATHOPHYSIOLOGY, IMMUNE CONSEQUENCES AND THERAPY, 2004, : 133 - 137
  • [49] Alternative (non-animal) method for TNFa production test
    Reyes, E
    Alonso-Lebrero, JL
    Brieva, A
    Mallo, AB
    Valdes-Hevia, MD
    Pivel, JP
    Alvarez-Mon, M
    SHOCK, 2004, 21 : 111 - 111
  • [50] The current landscape of non-animal preclinical assessment for biopharmaceuticals
    Grode, L.
    TOXICOLOGY LETTERS, 2024, 399 : S20 - S20